Compare BSAC & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSAC | HIMS |
|---|---|---|
| Founded | 1977 | 2017 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 12.2B |
| IPO Year | 1994 | N/A |
| Metric | BSAC | HIMS |
|---|---|---|
| Price | $29.72 | $39.53 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 11 |
| Target Price | $26.67 | ★ $44.56 |
| AVG Volume (30 Days) | 333.3K | ★ 21.3M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | ★ 42.15 | 20.76 |
| EPS | 0.01 | ★ 0.54 |
| Revenue | ★ $2,434,135,287.00 | $2,210,958,000.00 |
| Revenue This Year | $41.31 | $62.21 |
| Revenue Next Year | $5.39 | $18.79 |
| P/E Ratio | ★ $12.84 | $73.02 |
| Revenue Growth | 20.98 | ★ 78.02 |
| 52 Week Low | $18.19 | $23.97 |
| 52 Week High | $31.16 | $72.98 |
| Indicator | BSAC | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 53.37 | 47.70 |
| Support Level | $29.05 | $35.78 |
| Resistance Level | $29.58 | $39.87 |
| Average True Range (ATR) | 0.54 | 2.24 |
| MACD | -0.01 | 0.81 |
| Stochastic Oscillator | 41.32 | 78.91 |
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.